StockData
Turn Therapeutics Inc. logo

Turn Therapeutics Inc. (TTRX) stock

TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 2/30
$9.35−0.79 (-7.75%)

Close on Nov 13, 2026Market cap $278.37MP/E –Yield –

Turn Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Turn Therapeutics's total debt was $6.19M at Sep 30, 2026.

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$6.19M–
Q2 FY2026Jun 30, 2026$6.06M–
Q1 FY2026Mar 31, 2026$5.94M–

More Turn Therapeutics figures

See a number that looks wrong?